The Association of Kidney Function on Survival in Patients with AL Amyloidosis after Autologous Stem Cell Transplantation
Kidney360 · 2025
DOI: 10.34067/kid.0000001036 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Kidney360, 2025. Verfasst von Umut Selamet und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Glomerular Filtration Rate, Kidney, Hematopoietic Stem Cell Transplantation. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH-Cancer support grant.
Abstract (Originalsprache)
Background
We investigated how kidney function impacted progression-free survival (PFS) and overall survival (OS) after autologous stem cell transplantation (ASCT) in patients with AL amyloidosis.
Methods
We performed a retrospective cohort study of 314 patients with AL amyloidosis who underwent ASCT between 2010 and 2020. In addition to the baseline demographics, comorbidities, and kidney amyloidosis stage, eGFR) and other laboratory values were collected at day 0, day 100, 6 months, 1 year, 2 years, and 3 years after ASCT. The Cox proportional hazards models were used to estimate hazard ratio based on landmark analysis for the effects of eGFR and other longitudinal measures on PFS or OS.
Results
Higher eGFR values at all time points after ASCT were not significantly associated with longer PFS but was associated with increased OS. Patients with kidney amyloidosis stage III at baseline had inferior OS compared to those who had stage I [HR (95% CI) = 9.428 (1.134, 78.381), p-value = 0.0379]. OS was better in those who had complete kidney response irrespective of the baseline kidney amyloidosis stage, compared to those without response [HR (95% CI) = 7.581 (2.042, 28.149), p = 0.0025].
Conclusions
This retrospective study shows that kidney function has an impact on survival in patients with AL amyloidosis who undergo ASCT. Both higher eGFR at baseline and complete kidney response after ASCT favor improved survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
- Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts.
ORCID-Profile: Umut Selamet, Kole Joachim, Heather Lin, Ruby Delgado, Shveta S Motwani, Giada Bianchi, Naoka Murakami, Ala Abudayyeh
Förderung
- NIDDK NIH HHS
- NIH-Cancer support grant
Zitieren
APA
Selamet, U., Joachim, K., Lin, H., Rondon, G., Martinez, C. S., Delgado, R., Page, V., Motwani, S. S., Dincer, B., Bianchi, G., Qazilbash, M., Murakami, N., & Abudayyeh, A. (2025). The Association of Kidney Function on Survival in Patients with AL Amyloidosis after Autologous Stem Cell Transplantation. Kidney360. https://doi.org/10.34067/kid.0000001036
Vancouver
Selamet U, Joachim K, Lin H, Rondon G, Martinez CS, Delgado R, et al. The Association of Kidney Function on Survival in Patients with AL Amyloidosis after Autologous Stem Cell Transplantation. Kidney360. 2025. doi:10.34067/kid.0000001036
BibTeX
@article{Selamet2025,
author = {Selamet, Umut and Joachim, Kole and Lin, Heather and Rondon, Gabriela and Martinez, Charles S and Delgado, Ruby and Page, Valda and Motwani, Shveta S and Dincer, Berkay and Bianchi, Giada and Qazilbash, Muzaffar and Murakami, Naoka and Abudayyeh, Ala},
title = {The Association of Kidney Function on Survival in Patients with AL Amyloidosis after Autologous Stem Cell Transplantation},
journal = {Kidney360},
year = {2025},
doi = {10.34067/kid.0000001036}
}
EUVIMED